Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Mecasermin 10-mg/mL Injection

Author(s):  Allen Loyd V Jr

Issue:  Mar/Apr 2014 - Volume 18, Number 2
View All Articles in Issue

Page(s):  144

Mecasermin 10-mg/mL Injection Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Mecasermin 10-mg/mL Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, mecasermin, insulin-like growth factor 1, rhIGF-1, somatomedin C, formulation, diabetes mellitus, amyotrophic lateral sclerosis, growth hormone insensitivity, growth disorders, intravenous administration, compounded sterile preparations

Related Categories: FORMULATIONS, STERILE PREPARATIONS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, NEUROLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Mecasermin 10-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 144

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Five Compounds for Treating Diabetes-Related Conditions
Meece Jerry
May/Jun 2003
Pg. 170-174

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Basics of Compounding for Cough
Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465

Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Allen Loyd V Jr
Nov/Dec 2022
Pg. 446-466

Biotin Regulates Colonization and Growth of Candida albicans in the Catheter Lumen During Nutrient Infusions
Ohara Hiroshi
, Matsuzaki Tetsuya, Ochiai Tatsuya, Hayasaka Masataka
Sep/Oct 2020
Pg. 420-425

Profile: The McGuff Companies, Part 2: Corporate Cooperation Supports Growth and Ensures Financial Success
Vail Jane
Jan/Feb 2006
Pg. 50-55

Continued Growth Predicted for Home Infusion Market
Allen Loyd V Jr
Sep/Oct 1997
Pg. 298

Diabetes Book Reviews
Reed-Kane Dana
Mar/Apr 2000
Pg. 103-104

Diabetes Mellitus: Pathophysiology and Complications
Meece Jerry
Jan/Feb 2003
Pg. 17-20

The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna
, Neuenschwander Pierre F, Kurdowska Anna K
Jan/Feb 2013
Pg. 74-85

View Sample
Complications of Diabetes
Key David M
Mar/Apr 2000
Pg. 88-90

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
Jan/Feb 2023
Pg. 53

The History of Pluronic Lecithin Organogel: An Interview With Marty Jones, BSPharm, FACA, FIACP
Allen Loyd V Jr
May/Jun 2003
Pg. 180-183

Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens-Part 1
Ford Gina
, Garcia Lea
Nov/Dec 2000
Pg. 421-422

Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2
Ford Gina
, Garcia Lea
Jan/Feb 2001
Pg. 52-54

Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection
Allen Loyd V Jr
Sep/Oct 2010
Pg. 428

Imatinib 40-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 510

Return to Top